154 related articles for article (PubMed ID: 38265529)
21. Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours.
Pedraza AM; Stephenson AJ
Curr Opin Urol; 2018 Sep; 28(5):448-453. PubMed ID: 29979237
[TBL] [Abstract][Full Text] [Related]
22. Clinical profile, treatment and survival outcome of testicular tumors: a pakistani perspective.
Bhatti AB; Ahmed I; Ghauri RK; Saeed Q; Mir K
Asian Pac J Cancer Prev; 2014; 15(1):277-80. PubMed ID: 24528039
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and treatment of urological malignancy: the testes.
Wilkins M; Horwich A
Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):199-203. PubMed ID: 8777501
[TBL] [Abstract][Full Text] [Related]
24. [Metachronous testicular seminoma with an interval of 14 years from the first nonseminomatous testicular tumor: a case report].
Kawasaki M; Satoh Y; Nakashima K; Nishimura K; Kaneko A; Udoh K; Fujiyama C; Uozumi J
Nihon Hinyokika Gakkai Zasshi; 2009 Jan; 100(1):16-21. PubMed ID: 19198225
[TBL] [Abstract][Full Text] [Related]
25. Contemporary Incidence and Mortality Rates in Patients With Testicular Germ Cell Tumors.
Palumbo C; Mistretta FA; Mazzone E; Knipper S; Tian Z; Perrotte P; Antonelli A; Montorsi F; Shariat SF; Saad F; Simeone C; Briganti A; Lattouf JB; Karakiewicz PI
Clin Genitourin Cancer; 2019 Oct; 17(5):e1026-e1035. PubMed ID: 31378580
[TBL] [Abstract][Full Text] [Related]
26. Multifocality in testicular germ cell tumor (TGCT): what is the significance of this finding?
Favilla V; Russo GI; Spitaleri F; Urzì D; Garau M; Madonia M; Saita A; Pirozzi Farina F; La Vignera S; Condorelli R; Calogero AE; Cimino S; Morgia G
Int Urol Nephrol; 2014 Jun; 46(6):1131-5. PubMed ID: 24318367
[TBL] [Abstract][Full Text] [Related]
27. Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014.
Tabakin AL; Shinder BM; Kim S; Rivera-Nunez Z; Polotti CF; Modi PK; Sterling JA; Farber NJ; Radadia KD; Parikh RR; Kim IY; Saraiya B; Mayer TM; Singer EA; Jang TL
Clin Genitourin Cancer; 2020 Apr; 18(2):e194-e201. PubMed ID: 31818649
[TBL] [Abstract][Full Text] [Related]
28. Hospital procedure volume and prognosis with respect to testicular cancer patients: a population-based study in Osaka, Japan.
Suzumura S; Ioka A; Nakayama T; Tsukuma H; Oshima A; Ishikawa O
Cancer Sci; 2008 Nov; 99(11):2260-3. PubMed ID: 19037976
[TBL] [Abstract][Full Text] [Related]
29. Primary tumor size thresholds in stage IA testicular seminoma: Implications for adjuvant therapy after orchiectomy and survival.
Azizi M; Peyton CC; Boulware DC; Gilbert SM; Sexton WJ
Urol Oncol; 2020 Jan; 38(1):7.e9-7.e18. PubMed ID: 31704139
[TBL] [Abstract][Full Text] [Related]
30. A nomogram for predicting survival and retroperitoneal lymph node dissection treatment in patients with resected testicular germ cell tumors.
Wu Y; Meyers JP; Shi G; Jin Z; Xia J; Gu Y; Qian Q; Hong Y
J Surg Oncol; 2019 Sep; 120(3):508-517. PubMed ID: 31140623
[TBL] [Abstract][Full Text] [Related]
31. When is a Seminoma not a Seminoma? The Incidence, Risk Factors and Management of Patients With Testicular Seminoma With Discordant Elevated Serum Alpha-fetoprotein.
Fero KE; Lec PM; Sharma V; Lenis AT; Low J; Litwin MS; Leapman MS; Chamie K
Urology; 2021 Nov; 157():188-196. PubMed ID: 34389428
[TBL] [Abstract][Full Text] [Related]
32. Construction and Validation of a Nomogram for Predicting Progression- Free Survival in Patients with Early-Stage Testicular Germ Cell Tumor.
Chen JG; Wang JQ; Peng TW; Chen ZS; Zhao SC
Recent Pat Anticancer Drug Discov; 2021; 16(1):44-53. PubMed ID: 33573563
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic predictors of outcomes in children with stage I testicular germ cell tumors: A pooled post hoc analysis of trials from the Children's Oncology Group.
Singla N; Wong J; Singla S; Krailo M; Huang L; Shaikh F; Billmire D; Rescorla F; Ross J; Dicken B; Amatruda JF; Lindsay Frazier A; Bagrodia A
J Pediatr Urol; 2022 Aug; 18(4):505-511. PubMed ID: 35606324
[TBL] [Abstract][Full Text] [Related]
34. Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation of biomarkers.
Lobo J; Gillis AJM; van den Berg A; Looijenga LHJ
BMC Cancer; 2020 Aug; 20(1):728. PubMed ID: 32758242
[TBL] [Abstract][Full Text] [Related]
35. Risk and prognostic significance of metachronous contralateral testicular germ cell tumours.
Schaapveld M; van den Belt-Dusebout AW; Gietema JA; de Wit R; Horenblas S; Witjes JA; Hoekstra HJ; Kiemeney LA; Louwman WJ; Ouwens GM; Aleman BM; van Leeuwen FE
Br J Cancer; 2012 Oct; 107(9):1637-43. PubMed ID: 23059747
[TBL] [Abstract][Full Text] [Related]
36. Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology.
Bilici A; Ozturk T; Turkmen E; Odabas H; Cihan S; Selcukbiricik F; Erdogan B; Urakci Z; Kandemir N; Bayoglu IV; Demirci U; Duran AO; Sendur MA; Yavuzer D; Harputluoglu H; Kavgaci H; Gumus M
World J Urol; 2015 Oct; 33(10):1613-22. PubMed ID: 25605506
[TBL] [Abstract][Full Text] [Related]
37. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
38. Prognostic and predictive factors in testicular cancer.
Facchini G; Rossetti S; Berretta M; Cavaliere C; D'Aniello C; Iovane G; Mollo G; Capasso M; Della Pepa C; Pesce L; Facchini S; Imbimbo C; Pisconti S
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3885-3891. PubMed ID: 31115016
[TBL] [Abstract][Full Text] [Related]
39. The clinical features and management of testicular germ cell tumours in patients aged 60 years and older.
Wheater MJ; Manners J; Nolan L; Simmonds PD; Hayes MC; Mead GM
BJU Int; 2011 Dec; 108(11):1794-9. PubMed ID: 21627751
[TBL] [Abstract][Full Text] [Related]
40. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S
Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
